Synergy Pharmaceuticals to acquire FV-100 shingles drug from Bristol-Myers Squibb - MarketLine Financial Deals

Synergy Pharmaceuticals to acquire FV-100 shingles drug from Bristol-Myers Squibb

Synergy Pharmaceuticals to acquire FV-100 shingles drug from Bristol-Myers Squibb - MarketLine Financial Deals
Synergy Pharmaceuticals to acquire FV-100 shingles drug from Bristol-Myers Squibb
Published Aug 23, 2012
3 pages — Published Aug 23, 2012
Price US$ 20.00  |  Buy this Report Now

About This Report

  
Abstract:

Synergy Pharmaceuticals, Inc., a biopharmaceutical company focused on the development of new drugs to treat gastrointestinal disorders and diseases, has entered into an asset purchase agreement to acquire assets related to FV-100 from Bristol-Myers Squibb Company, a pharmaceuticals company.

  
Source:
Document ID
MA120398_120828
Country
Ticker
BMY=US
Ticker
SGYP=US
Format:
PDF Adobe Acrobat
Buy Now

MarketLine Financial Deals—MarketLine Financial Deals – Identifying and tracking major financial activity across our full scope of company and sector coverage, MarketLine Financial Deals covers mergers & acquisitions, private equity/venture capital backed buyouts, investments, and exits, IPOs and secondary and follow on offerings, and private placements and exits. Additional non-corporate financial deals including partnership agreements, joint ventures, co-development and research, licensing and co-marketing agreements are also available.

About the Author


Cite this Report

  
MLA:
MarketLine Financial Deals. "Synergy Pharmaceuticals to acquire FV-100 shingles drug from Bristol-Myers Squibb" Aug 23, 2012. Alacra Store. Dec 07, 2016. <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/Synergy-Pharmaceuticals-to-acquire-FV-100-shingles-drug-from-Bristol-Myers-Squibb-2052-85754>
  
APA:
MarketLine Financial Deals. (2012). Synergy Pharmaceuticals to acquire FV-100 shingles drug from Bristol-Myers Squibb Aug 23, 2012. New York, NY: Alacra Store. Retrieved Dec 07, 2016 from <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/Synergy-Pharmaceuticals-to-acquire-FV-100-shingles-drug-from-Bristol-Myers-Squibb-2052-85754>
  
US$ 20.00
$  £  
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our MarketLine Financial Deals from one place.